Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical announced a collaboration to jointly develop 3D printed medical devices. Both complementary companies jointly span the complete process, from initial design idea over medical engineering to legal manufactured devices ready for use. The business focus and technology expertise shared by Amnovis and BAAT Medical, lead to more innovative business models and better 3D printed medical devices. Their joint technology roadmap, focused on the development of new medical device applications and the validation of state-of-the-art AM technologies and related processes, pushes medical device innovation. This enables medical device startups and OEMs to benefit from faster time to market of 3D printed medical devices that excel in patient outcome.
BAAT Medical has pioneered the engineering and development of 3D printed spinal fusion implants, resulting in multiple CE marks and FDA approvals and more than 50,000 implants manufactured to date. The Amnovis’ founders have a proven track record, going back to 2008, in using AM to make high-end products. They were among the first to employ L-PFB for printing titanium medical devices, such as orthopedic and spinal implants.
The collaboration between Amnovis and BAAT Medical combines the best of both companies. Together, they have a more comprehensive view on how to optimally tune design and development as well as material selection and manufacturing in context of specific AM medical device applications. Both companies work on a joint technology and application roadmap and actively validate new AM technologies to set new standards for specific medical device types. They align these efforts with the business potential and time to market of new AM technologies in the medical sector. As part of this effort, they drill down deeper on AM materials and post-processing methods as well as process automation and validation.
Ruben Wauthle, CEO and Co-founder of Amnovis: "We are extremely proud to collaborate with BAAT Medical. We see great potential in jointly innovating various AM medical device applications. We know each other for years, share the same innovative drive, and collaborate intensively to better align design and development with material selection and manufacturing. As preferred partners, our joint offering comprises of the complete process for customers and prospects to aim high and move fast, while removing hurdles in medical device development, validation and manufacturing. At Amnovis, we rely on our comprehensive AM workflow and production platform, which is entirely ISO 13485:2016 certified. Digital process automation enables us to provide full traceability and repeatability to flexibly scale up manufacturing of standard and patient-specific AM medical devices."
Gert Nijenbanning, Managing Director of BAAT Medical concludes: "Together we want to build on the complementary expertise of Amnovis and BAAT Medical to collaborate and take 3D printing of medical devices to the next level. As preferred partners, we are able to cover the complete process, from initial idea to a certified product. We partner to optimally use the possibilities of current and future AM technologies as part of new business models for medical devices with improved patient outcomes. Amnovis and BAAT Medical, together, push the innovative edge of medical device OEMs and move faster through the development, validation and manufacturing stages.”
Remember, you can post job opportunities in the AM Industry on 3D ADEPT Media free of charge or look for a job via our job board. Make sure to follow us on our social networks and subscribe to our weekly newsletter : Facebook, Twitter, LinkedIn & Instagram ! If you want to be featured in the next issue of our digital magazine or if you hear a story that needs to be heard, make sure to send it to contact@3dadept.com